Patents by Inventor Olivier Tabary

Olivier Tabary has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination treatment for cystic fibrosis
    Patent number: 11261445
    Abstract: Cystic fibrosis (CF) is a genetic disease caused by mutations in the gene encoding the 5 CFTR Cl— channel and affects several organs, but the most severe consequences are observed in the lung. The inventors have now instigated the combination of Orkambi® and ANO1 TSB (SEQ ID NO:1) and show that said combination increases mucociliary clearance and chloride channel activity. Thus the combination represents an alternative treatment for CF subjects.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: March 1, 2022
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), SORBONNE UNIVERSITE, ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP)
    Inventors: Olivier Tabary, Florence Sonneville, Harriet Corvol
  • Methods and pharmaceutical compositions for the treatment of cystic fibrosis
    Patent number: 11130950
    Abstract: The present invention relates to methods and pharmaceutical compositions for the treatment of cystic fibrosis. In particular, the present invention relates to a method of treating cystic fibrosis in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a nucleic acid miR-9 inhibitor.
    Type: Grant
    Filed: July 1, 2016
    Date of Patent: September 28, 2021
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), SORBONNE UNIVERSITÉ
    Inventors: Olivier Tabary, Florence Sonneville
  • COMBINATION TREATMENT FOR CYSTIC FIBROSIS
    Publication number: 20210189390
    Abstract: Cystic fibrosis (CF) is a genetic disease caused by mutations in the gene encoding the 5 CFTR Cl— channel and affects several organs, but the most severe consequences are observed in the lung. The inventors have now instigated the combination of Orkambi® and ANO1 TSB (SEQ ID NO:1) and show that said combination increases mucociliary clearance and chloride channel activity. Thus the combination represents an alternative treatment for CF subjects.
    Type: Application
    Filed: October 16, 2018
    Publication date: June 24, 2021
    Inventors: Olivier TABARY, Florence SONNEVILLE, Harriet CORVOL
  • METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CYSTIC FIBROSIS
    Publication number: 20200040332
    Abstract: The present invention relates to methods and pharmaceutical compositions for the treatment of cystic fibrosis. In particular, the present invention relates to a method of treating cystic fibrosis in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a nucleic acid miR-9 inhibitor.
    Type: Application
    Filed: July 1, 2016
    Publication date: February 6, 2020
    Inventors: Olivier TABARY, Florence SONNEVILLE
  • Hypoosmotic saline solutions, method for preparing same and medicines based on said solution
    Patent number: 6921540
    Abstract: The present invention provides novel hypoosmotic saline compositions and their use as medicines for the prevention of the release of chemical mediators responsible for triggering phenomena causing inflammation of mucous membranes, and for the dissolution of cerumen plugs located in the external auditory meatus.
    Type: Grant
    Filed: July 5, 1999
    Date of Patent: July 26, 2005
    Assignee: Laboratoires Goemar SA
    Inventors: Jean-Claude Yvin, Didier Leroy, Olivier Tabary, Jacky Jacquot, Edith Puchele
  • Use of iso-osmotic saline solutions, method for preparing same and cerumenolytic medicines based on said solutions
    Patent number: 6709680
    Abstract: The invention concerns the use of iso-osmotic saline solutions, in particular obtained from sea water, to obtain a medicine for cerumenolytic treatment.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: March 23, 2004
    Assignee: Laboratories Goemar S.A.
    Inventors: Jean-Claude Yvin, Isabelle Cadulal, Olivier Tabary
  • Use of iso-osmotic saline solutions, method for preparing same and medicine based on said solutions
    Patent number: 6451352
    Abstract: The invention concerns the use of iso-osmotic saline solutions in particular obtained from sea water, to obtain a medicine designed for a treatment preventing and limiting the release of chemical mediators responsible for causing inflammatory phenomena in the human respiratory tracts.
    Type: Grant
    Filed: May 24, 2001
    Date of Patent: September 17, 2002
    Assignee: Laboratoires Goemar S.A.
    Inventors: Jean-Claude Yvin, Olivier Tabary, Jacky Jacquot, Edith Puchelle